+ Larger Font | - Smaller Font
Share


Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Science News New Immunotherapy Drugs Target Two Evasive Cancer Driving Proteins Science Magazine is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.
Search RobinsPost News & Noticias


Science News New Immunotherapy Drugs Target Two Evasive Cancer Driving Proteins Science Magazine | RobinsPost News & Noticias

Trial for immunotherapy drug shows promise for aggressive breast cancer


University of Hawaiʻi Cancer Center researchers have conducted a phase II clinical trial investigating the potential of pembrolizumab maintenance therapy, a type of immunotherapy, in aggressive forms ... Read More

Super-Quiz for Science


A version of this article appears in the February 2, 1952 issue of Science News. Love our Health & Medicine stories? Our coverage would not be possible without the generous support of subscribers ... Read More

Lung Cancer News


Genetic Signature May Predict Response to Immunotherapy ... A novel drug target has been newly identified in the fight against drug resistance in cancer ... Small Cell Lung Cancer: New Approach ... Read More

Structures of new cancer drug candidates revealed


The company plans to partner with Pfizer on a Phase 2 study. The cancer immunotherapy ... therapies that target RTK proteins. However, cancer cells can resist these drugs using a mechanism called ... Read More

Prostate Cancer News


Promising New Options for Treating Aggressive Prostate Cancer Oct. 18, 2023 — Investigators have identified two ... drug, a multi-institution, Phase 3 clinical trial has ... New Approach to ... Read More

New insights could unlock immunotherapy for rare, deadly eye cancer


New research from the University of Pittsburgh explains why metastatic uveal melanoma is resistant to conventional immunotherapies and how adoptive therapy, which involves growing a patient’s T cells ... Read More

New trial shows immunotherapy post-surgery improves overall survival for kidney cancer


For the first time in fifty years, results from a Phase 3 randomized, placebo-controlled trial have shown an overall survival benefit from an adjuvant therapy in patients with kidney cancer. Read More

The Next Generation of Cancer Drugs Will Be Made in Space


Immunotherapy is one of the most promising new ways to fight cancer ... that microgravity can give to life science research, drug development, cancer research—and more that we just don't ... Read More

Smart News Science


millions of Americans looked up and were spellbound by the spectacular phenomenon Two specific broods will appear together for the first time since 1803 The two babies are part of an endangered ... Read More

Science


April 17, 2024 • 500 million years ago, the world was a very different place. During this period of time, known as the Cambrian period, basically all life was in the water. The ocean was ... Read More

Scientists discover new 'wonder' drug for aggressive cancer


Half were also given injections of new drug, ADI-PEG20 (pegargiminase) while the other half received a placebo – also known as a dummy drug – for two ... science engagement manager at Cancer ... Read More

The New Science of Death


We preselected all newsletters you had before unsubscribing. Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus